Vellanki Avanish 4
4 · Rain Oncology Inc. · Filed Aug 11, 2023
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-08-09+133,250→ 133,250 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (133,250 underlying) - Award
Stock Option (Right to Buy)
2023-08-09+266,500→ 266,500 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (266,500 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 266,500 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 133,250 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer.